UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 941

Sortiert nach

CAM: Causal additive models, high-dimensional order search and penalized regression

The Annals of statistics, 2014-12, Vol.42 (6)

2014

Volltextzugriff (PDF)

Biosimilar SB15 versus reference aflibercept in neovascular age-related macular degeneration: 1-year and switching results of a phase 3 clinical trial

BMJ open ophthalmology, 2023-12, Vol.8 (1), p.e001561

2023

Volltextzugriff (PDF)

Plasma Amino Acids May Improve Prediction Accuracy of Cerebral Vasospasm after Aneurysmal Subarachnoid Haemorrhage

Journal of clinical medicine, 2022-01, Vol.11 (2), p.380

2022

Volltextzugriff (PDF)

Three cases of ectopic sphenoid sinus pituitary adenoma

Folia neuropathologica, 2017-01, Vol.55 (1), p.60-66

2017

Volltextzugriff (PDF)

CAM: CAUSAL ADDITIVE MODELS, HIGH-DIMENSIONAL ORDER SEARCH AND PENALIZED REGRESSION

The Annals of statistics, 2014-12, Vol.42 (6), p.2526-2556

2014

Volltextzugriff (PDF)

CAUSAL INFERENCE IN PARTIALLY LINEAR STRUCTURAL EQUATION MODELS

The Annals of statistics, 2018-12, Vol.46 (6A), p.2904-2938

2018

Volltextzugriff (PDF)

Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial

JAMA ophthalmology, 2021-01, Vol.139 (1), p.68

2021

Volltextzugriff (PDF)

Anatomical and Radiological Analysis of Structures of Petrous Part of the Temporal Bone and Their Impact on Area of Anterior Petrosectomy

World neurosurgery, 2024-06

2024

Volltextzugriff (PDF)

Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema

Ophthalmology (Rochester, Minn.), 2014-10, Vol.121 (10), p.1904-1914

2014

Volltextzugriff (PDF)

Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes

British journal of ophthalmology, 2023-03, Vol.107 (3), p.384

2023

Volltextzugriff (PDF)

Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration: A Phase 3 Randomized Clinical Trial

JAMA ophthalmology, 2023-07, Vol.141 (7), p.668

2023

Volltextzugriff (PDF)

RETROSPECTIVE ANALYSIS OF THE PRESENCE OF CHOROIDAL NEOVASCULARISATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY WITH THE AID OF PHOTODYNAMIC THERAPY

Česká a slovenská oftalmologie, 2021, Vol.77 (3), p.122

2021

Volltextzugriff (PDF)

Validation of the Elderly Traumatic Brain Injury Score: Observational Case Control Study

World neurosurgery, 2022-05, Vol.161, p.e464-e472

2022

Volltextzugriff (PDF)

Vogt-Koyanagi-Harada Syndrome (Uveomeningoencephalitic Syndrome)

European journal of ophthalmology, 2017-01, Vol.27 (1), p.5-8

2017

Volltextzugriff (PDF)

Reuse of Nasoseptal Flaps for Endoscopic Endonasal Skull Base Reconstruction

Journal of neurological surgery. Part B, Skull base, 2023-08

2023

Volltextzugriff (PDF)

Randomized Trial of Biosimilar XSB-001 versus Reference Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration

Ophthalmology retina, 2023-09, Vol.7 (9), p.753-761

2023

Volltextzugriff (PDF)

Plasma amino acids indicate glioblastoma with ATRX loss

Amino acids, 2021, Vol.53 (1), p.119-132

2021

Volltextzugriff (PDF)

Stereotactic radiotherapy for neovascular age-related macular degeneration: 52-week safety and efficacy results of the INTREPID study

Ophthalmology (Rochester, Minn.), 2013-09, Vol.120 (9), p.1893-1900

2013

Volltextzugriff (PDF)

One-Year Results of Fixed Aflibercept Treatment Regime in Type 3 Neovascularization

Ophthalmologica (Basel), 2020-01, Vol.243 (1), p.58-65

2020

Volltextzugriff (PDF)

Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration Beyond One Year of Treatment: AZURE, a Randomized Trial of Treat-and-Extend vs. Fixed Dosing

Advances in therapy, 2024-03, Vol.41 (3), p.1010-1024

2024

Volltextzugriff (PDF)

SCHEMES WITH WELL-CONTROLLED DISSIPATION

SIAM journal on numerical analysis, 2015-01, Vol.53 (1), p.674-699

2015

Volltextzugriff (PDF)

Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

The Lancet (British edition), 2024-03, Vol.403 (10432), p.1153-1163

2024

Volltextzugriff (PDF)

Suprasellar Epidermoid Cyst: Case Report of Extended Endoscopic Transsphenoidal Resection and Systematic Review of the Literature

World neurosurgery, 2019-08, Vol.128, p.514-526

2019

Volltextzugriff (PDF)

A Phase 2/3, Multicenter, Randomized, Double-Masked, 2-Year Trial of Pegaptanib Sodium for the Treatment of Diabetic Macular Edema

Ophthalmology (Rochester, Minn.), 2011-06, Vol.118 (6), p.1107-1118

2011

Volltextzugriff (PDF)

1 – 25 von 941

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(594)
Mit Volltextzugriff
(871)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

CAM: Causal additive models, high-dimensional order search and penalized regression

Biosimilar SB15 versus reference aflibercept in neovascular age-related macular degeneration: 1-year and switching results of a phase 3 clinical trial

Prophylactic use of dural tenting sutures in elective craniotomies in adults-is it necessary? A study protocol for a multicentre, investigator- and participant-blinded randomised, parallel-group, non-inferiority trial

Plasma Amino Acids May Improve Prediction Accuracy of Cerebral Vasospasm after Aneurysmal Subarachnoid Haemorrhage

Three cases of ectopic sphenoid sinus pituitary adenoma

CAM: CAUSAL ADDITIVE MODELS, HIGH-DIMENSIONAL ORDER SEARCH AND PENALIZED REGRESSION

CAUSAL INFERENCE IN PARTIALLY LINEAR STRUCTURAL EQUATION MODELS

Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial

Anatomical and Radiological Analysis of Structures of Petrous Part of the Temporal Bone and Their Impact on Area of Anterior Petrosectomy

Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema

Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes

Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration: A Phase 3 Randomized Clinical Trial

RETROSPECTIVE ANALYSIS OF THE PRESENCE OF CHOROIDAL NEOVASCULARISATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY WITH THE AID OF PHOTODYNAMIC THERAPY

Validation of the Elderly Traumatic Brain Injury Score: Observational Case Control Study

Vogt-Koyanagi-Harada Syndrome (Uveomeningoencephalitic Syndrome)

Reuse of Nasoseptal Flaps for Endoscopic Endonasal Skull Base Reconstruction

Randomized Trial of Biosimilar XSB-001 versus Reference Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration

Plasma amino acids indicate glioblastoma with ATRX loss

Stereotactic radiotherapy for neovascular age-related macular degeneration: 52-week safety and efficacy results of the INTREPID study

One-Year Results of Fixed Aflibercept Treatment Regime in Type 3 Neovascularization

Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration Beyond One Year of Treatment: AZURE, a Randomized Trial of Treat-and-Extend vs. Fixed Dosing

SCHEMES WITH WELL-CONTROLLED DISSIPATION

Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

Suprasellar Epidermoid Cyst: Case Report of Extended Endoscopic Transsphenoidal Resection and Systematic Review of the Literature

A Phase 2/3, Multicenter, Randomized, Double-Masked, 2-Year Trial of Pegaptanib Sodium for the Treatment of Diabetic Macular Edema

Suchergebnisse filtern